Test time has arrived: the first person has been treated in a highly anticipated gene-therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial is testing an ...
In the present study, we sought to evaluate differences in clinical outcomes and toxicity profiles between elderly patients aged 70 years and older and their younger counterparts. By identifying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results